A Study of RD06-04 in Patients With Active Autoimmune Diseases

Clinical trial NCT06548620 · WITHDRAWN

Trial details

NCT number: NCT06548620
Sponsor: Nanjing Bioheng Biotech Co., Ltd.
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

SLE Sclerosis ANCA Associated Vasculitis IIM SS MS NMO Spectrum Disorder MG

Start date: 2024-08-31
Primary completion: 2026-08-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.